货号:A651692
同义名:
(+)-四苯那嗪
/ (+)-TBZ; (3R,11bR)-TBZ
Tetrabenazine (+)- is a potent, selective and reversible VMAT-2 (vesicular monoamine transporter-2) inhibitor with Ki value of 100 nM.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Vesicular monoamine transporter 2 (VMAT2) is a transmembrane protein that regulates the packaging and subsequent release of monoamine neurotransmitter molecules from neuronal vesicles into synapses. Tetrabenazine is a reversible inhibitor of VMAT2 that inhibits [3H]serotonin transport by VMAT2 with an IC50 value of ~300nM[3]. Injection of tetrabenazine at a dosage of 2.0mg/kg induced tremulous jaw movements in rats, while this effect was significantly attenuated by deprenyl, a monoamine oxidase type B inhibitor. Tetrabenazine at 2.0 mg/kg also had a biphasic effect on striatal extracellular dopamine in rats, which resulted in a remarkable increase (100%) in extracellular dopamine 30 minutes after injection, followed by a significant reduction (50%) after 90 minutes[4]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.15mL 0.63mL 0.32mL |
15.75mL 3.15mL 1.58mL |
31.50mL 6.30mL 3.15mL |
CAS号 | 1026016-83-0 |
分子式 | C19H27NO3 |
分子量 | 317.42 |
SMILES Code | O=C([C@H](CC(C)C)C1)C[C@@]2([H])N1CCC3=C2C=C(OC)C(OC)=C3 |
MDL No. | MFCD08461052 |
别名 | (+)-四苯那嗪 ;(+)-TBZ; (3R,11bR)-TBZ; (3R,11bR)-Tetrabenazine |
运输 | 蓝冰 |
InChI Key | MKJIEFSOBYUXJB-GDBMZVCRSA-N |
Pubchem ID | 667453 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|